Improving the next generation of bioartificial liver devices.

Several extracorporeal bioartificial liver (BAL) devices are currently being evaluated as an alternative or adjunct therapy for liver disease. While these hybrid systems show promise, in order to become a clinical reality, BAL devices must clearly demonstrate efficacy in improving patient outcomes. Here, we present aspects of BAL devices that could benefit from fundamental advances in cell and developmental biology. In particular, we examine the development of human hepatocyte cell lines, strategies to stabilize the hepatocyte phenotype in vitro, and emphasize the importance of the cellular microenvironment in bioreactor design. Consideration of these key components of BAL systems will greatly improve next generation devices.

[1]  K. Asano,et al.  Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. , 1990, Experimental cell research.

[2]  S. Bhatia,et al.  Advances in bioartificial liver devices , 2001, Hepatology.

[3]  L. Podestá,et al.  A Bioartificial Liver to Treat Severe Acute Liver Failure , 1994, Annals of surgery.

[4]  G. Michalopoulos,et al.  Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium , 1996, The Journal of cell biology.

[5]  M. Sakaguchi,et al.  Construction of a Differentiated Human Hepatocyte Cell Line Expressing the Herpes Simplex Virus-Thymidine Kinase Gene , 2001, ASAIO journal.

[6]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[7]  Y. Sakai,et al.  Development of a new bioartificial liver module filled with porcine hepatocytes immobilized on non-woven fabric. , 1996, The International journal of artificial organs.

[8]  S. Nyberg,et al.  Hepatocyte liver-assist systems--a clinical update. , 1998, Mayo Clinic proceedings.

[9]  S. Cascio Novel strategies for immortalization of human hepatocytes. , 2001, Artificial organs.

[10]  G. Michalopoulos,et al.  Serum-free, long-term cultures of human hepatocytes: maintenance of cell morphology, transcription factors, and liver-specific functions. , 2000, Biochemical and biophysical research communications.

[11]  A. Demetriou,et al.  Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. , 1997, Annals of surgery.

[12]  H. Jauregui,et al.  Isolation and culture of porcine hepatocytes for artificial liver support. , 1996, Cell transplantation.

[13]  R. Taub,et al.  Coexpression of liver‐specific and growth‐induced genes in perinatal and regenerating liver: Attainment and maintenance of the differentiated state during rapid proliferation , 1995, Hepatology.

[14]  J. Merchuk,et al.  Hepatocyte behavior within three-dimensional porous alginate scaffolds. , 2000, Biotechnology and bioengineering.

[15]  J. Encke,et al.  Bioreactor for a larger scale hepatocyte in vitro perfusion. , 1994, Transplantation.

[16]  J. Dich,et al.  Long‐term culture of hepatocytes: Effect of hormones on enzyme activities and metabolic capacity , 1988, Hepatology.

[17]  P. Briand,et al.  Immortalization of a primate bipotent epithelial liver stem cell , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R Williams,et al.  Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure , 1996, Hepatology.

[19]  A. Guillouzo,et al.  Maintenance and reversibility of active albumin secretion by adult rat hepatocytes co-cultured with another liver epithelial cell type. , 1983, Experimental cell research.

[20]  R. Tompkins,et al.  Long‐Term in Vitro Function of Adult Hepatocytes in a Collagen Sandwich Configuration , 1991, Biotechnology progress.

[21]  J. Patzer,et al.  Advances in Bioartificial Liver Assist Devices , 2001, Annals of the New York Academy of Sciences.

[22]  J. Lehmann,et al.  Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers. , 2000, Biotechnology and bioengineering.

[23]  W. D. Peterson,et al.  Performance of plasma-perfused, microencapsulated hepatocytes: prospects for extracorporeal liver support. , 1993, Journal of pediatric surgery.

[24]  M. Sakaguchi,et al.  Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. , 2000, Science.

[25]  P. Gruppuso,et al.  The Relationship between Differentiation and Proliferation in Late Gestation Fetal Rat Hepatocytes , 1999, Pediatric Research.

[26]  N. Douarin An experimental analysis of liver development. , 1975, Medical biology.

[27]  K. Zaret,et al.  Initiation of mammalian liver development from endoderm by fibroblast growth factors. , 1999, Science.

[28]  K Sugimachi,et al.  Evaluation of a hybrid artificial liver using a polyurethane foam packed-Bed culture system in dogs. , 1999, The Journal of surgical research.

[29]  M. Letarte,et al.  Establishment of a human hepatocyte line derived from primary culture in a collagen gel sandwich culture system. , 1995, Experimental cell research.

[30]  M V Peshwa,et al.  Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. , 1994, Annals of surgery.

[31]  N. Sussman,et al.  The Hepatix extracorporeal liver assist device: initial clinical experience. , 1994, Artificial organs.

[32]  Flat membrane bioreactor for the replacement of liver functions. , 2002, Ernst Schering Research Foundation workshop.

[33]  H. Jauregui,et al.  Isolation and Culture of Porcine Hepatocytes for Artificial Liver Support , 1996 .

[34]  T. Kiyono,et al.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells , 1998, Nature.

[35]  C. Selden,et al.  Three‐dimensional in Vitro Cell Culture Leads to a Marked Upregulation of Cell Function in Human Hepatocyte Cell Lines‐an Important Tool for the Development of a Bioartificial Liver Machine , 1999, Annals of the New York Academy of Sciences.

[36]  P. Laterre,et al.  An interim analysis of a phase II/III prospective randomized, multicenter, controlled trial of the HepatAssist (R) bioartificial liver support system for the treatment of fulminant hepatic failure. , 2001 .

[37]  J. Squire,et al.  Characterization of human hepatocyte lines derived from normal liver tissue , 1994, Hepatology.

[38]  O. Karlsen,et al.  UvA-DARE ( Digital Academic Repository ) In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates , 2001 .

[39]  M L Yarmush,et al.  Effect of cell–cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  N. Halpern,et al.  Bioartificial organ support for hepatic, renal, and hematologic failure. , 2000, Critical care clinics.

[41]  M. Pibiri,et al.  Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  B. Clement,et al.  Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver. , 1997, Transplantation.

[43]  T. Hassanein,et al.  The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. , 2002, Artificial organs.

[44]  Douarin Nm An experimental analysis of liver development. , 1975 .

[45]  M. Makuuchi,et al.  Efficacy of a bioreactor filled with porcine hepatocytes immobilized on nonwoven fabric for ex vivo direct hemoperfusion treatment of liver failure in pigs. , 1998, Artificial organs.

[46]  C. Mullon,et al.  Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. , 1999, Artificial organs.

[47]  M. Sakaguchi,et al.  Establishment of a highly differentiated immortalized human hepatocyte cell line as a source of hepatic function in the bioartificial liver. , 2000, Transplantation proceedings.

[48]  K. Jungermann,et al.  Oxygen: Modulator of metabolic zonation and disease of the liver , 2000, Hepatology.

[49]  S. Mizutani,et al.  Massive culture of human liver cancer cells in a newly developed radial flow bioreactor system: Ultrafine structure of functionally enhanced hepatocarcinoma cell lines , 1998, In Vitro Cellular & Developmental Biology - Animal.

[50]  M V Peshwa,et al.  Formation of porcine hepatocyte spheroids for use in a bioartificial liver. , 1995, Cell transplantation.

[51]  G. Mazariegos,et al.  Novel Bioartificial Liver Support System: Preclinical Evaluation , 1999, Annals of the New York Academy of Sciences.

[52]  C. Legallais,et al.  A new concept of bioartificial liver based on a fluidized bed bioreactor. , 1999, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[53]  G. Mazariegos,et al.  Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus. , 2002, Transplantation.

[54]  R. Busuttil,et al.  Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver. , 1997, Transplantation proceedings.

[55]  Naohiro Terada,et al.  Hepatic maturation in differentiating embryonic stem cells in vitro , 2001, FEBS letters.

[56]  H Conjeevaram,et al.  Safety of continuous human liver support. , 2001, Transplantation proceedings.

[57]  L. Reid,et al.  Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigen. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[58]  N. Sussman,et al.  Artificial liver: A forthcoming attraction , 1993, Hepatology.

[59]  J. Rossant,et al.  Liver Organogenesis Promoted by Endothelial Cells Prior to Vascular Function , 2001, Science.

[60]  L. Griffith,et al.  A microfabricated array bioreactor for perfused 3D liver culture. , 2002, Biotechnology and bioengineering.

[61]  Li Li,et al.  Comparison of Porcine Hepatocytes with Human Hepatoma (C3A) Cells for Use in a Bioartificial Liver Support System , 1998 .

[62]  E. Hsu,et al.  A novel multi‐coaxial hollow fiber bioreactor for adherent cell types. Part 1: Hydrodynamic studies , 2002, Biotechnology and Bioengineering.

[63]  David I. Wilson,et al.  Hepatic differentiation of murine embryonic stem cells. , 2001, Experimental cell research.

[64]  C. Woodworth,et al.  Maintenance of differentiated rat hepatocytes in primary culture. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Tompkins,et al.  Assessment of Artificial Liver Support Technology , 1992, Cell transplantation.

[66]  N. Marceau,et al.  Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities , 1985, The Journal of cell biology.

[67]  G. Michalopoulos,et al.  Primary culture of parenchymal liver cells on collagen membranes. Morphological and biochemical observations. , 1975, Experimental cell research.

[68]  N. Chowdhury,et al.  Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes. , 1997, Transplantation.

[69]  N Ohshima,et al.  Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydrogel. , 1989, ASAIO transactions.

[70]  M. Toner,et al.  Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. , 2001, Biotechnology and bioengineering.

[71]  J. Maher,et al.  Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. , 1987, The Journal of clinical investigation.

[72]  Peter J. Donovan,et al.  Derivation of pluripotent stem cells from cultured human primordial germ cells , 1998 .